Immune-mediated diseases of the colon such as inflammatory bowel disease may be related to a loss of tolerance to commensal bacteria. We have found that in the normal setting, colonic tolerance appears to be maintained via the recognition of commensal bacteria by inducible regulatory T (iTreg) cells. Based on our studies of the colonic TCR repertoire, we have generated two novel transgenic lines expressing bacteria- specific iTreg TCRs. This will allow us to directly assess bacteria-specific iTreg versus effector T cell differentiation under various experimental conditions.
In Aim 1, we will manipulate the bacterial population and determine their impact on iTreg cell generation using the TCR transgenic lines, as well as on a polyclonal CD4+ T cell population using TCR repertoire analysis.
In Aim 2, we will investigate the antigen-presenting cells and signals that are involved in T cell recognition of bacteria and differentiation into iTreg, rather than effector, cells. Finaly, in Aim 3, we will move beyond normal physiology and study the effect of infections as well as genetic mutations associated with IBD on iTreg cell development, addressing the hypothesis that CD4+ T cell tolerance is broken during immune mediated colitis. We believe that understanding the mechanisms which regulate the development and stability of bacteria-specific colonic iTreg cells will be useful for facilitating the development of Treg cell-mediated therapy fr IBD.

Public Health Relevance

Inflammatory bowel disease (IBD) afflicts approximately 0.1 - 0.2% of the general population, and causes significant morbidity and mortality from abdominal pain, weight loss, diarrhea, bleeding, and cancer. Current research suggests that genetic predisposition results in abnormal responses to commensal bacteria, and may result from a loss of T cell-mediated immune regulation to commensal bacteria. Thus, the goal of this proposal is to understand the mechanisms of T cell tolerance in the colon to potentially facilitate the development of novel therapies for IBD.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Grey, Michael J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Internal Medicine/Medicine
Schools of Medicine
Saint Louis
United States
Zip Code
Ai, Teresa L; Solomon, Benjamin D; Hsieh, Chyi-Song (2014) T-cell selection and intestinal homeostasis. Immunol Rev 259:60-74
Chai, Jiani N; Zhou, You W; Hsieh, Chyi-Song (2014) T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance. FEBS Lett 588:4167-75